Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032 - Yu, A L; Gilman, A L; Ozkaynak, M F (Clin Cancer Res, 2021)